These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16698918)

  • 1. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.
    Davis ME; Hsieh PC; Takahashi T; Song Q; Zhang S; Kamm RD; Grodzinsky AJ; Anversa P; Lee RT
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8155-60. PubMed ID: 16698918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction.
    Padin-Iruegas ME; Misao Y; Davis ME; Segers VF; Esposito G; Tokunou T; Urbanek K; Hosoda T; Rota M; Anversa P; Leri A; Lee RT; Kajstura J
    Circulation; 2009 Sep; 120(10):876-87. PubMed ID: 19704095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair.
    Jackson R; Tilokee EL; Latham N; Mount S; Rafatian G; Strydhorst J; Ye B; Boodhwani M; Chan V; Ruel M; Ruddy TD; Suuronen EJ; Stewart DJ; Davis DR
    J Am Heart Assoc; 2015 Sep; 4(9):e002104. PubMed ID: 26363004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of marrow-derived cardiac stem cells carried in designer self-assembling peptide nanofibers improves cardiac function after myocardial infarction.
    Guo HD; Cui GH; Wang HJ; Tan YZ
    Biochem Biophys Res Commun; 2010 Aug; 399(1):42-8. PubMed ID: 20637726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Controlled Release of Low Molecular Protein Insulin-like Growth Factor-1 through Self-Assembling Peptide Hydrogel with Biotin Sandwich Approach].
    Liu Y; Fan Z; Wang Y; Yu L
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Apr; 32(2):387-92. PubMed ID: 26211259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
    Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
    J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of biotinylated IGF-1 with biotinylated self-assembling peptides combined with bone marrow stem cell transplantation promotes cell therapy for myocardial infarction.
    Zhang M; Ai WW; Mei ZL; Hu YH; Zhang ZL
    Exp Ther Med; 2017 Oct; 14(4):3441-3446. PubMed ID: 29042931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway.
    Lin M; Liu X; Zheng H; Huang X; Wu Y; Huang A; Zhu H; Hu Y; Mai W; Huang Y
    Stem Cell Res Ther; 2020 Jan; 11(1):22. PubMed ID: 31918758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles enriched with miR-150 released by macrophages regulates the TP53-IGF-1 axis to alleviate myocardial infarction.
    Zheng S; Gong M; Chen J
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H969-H979. PubMed ID: 33164579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration.
    Kofidis T; de Bruin JL; Yamane T; Balsam LB; Lebl DR; Swijnenburg RJ; Tanaka M; Weissman IL; Robbins RC
    Stem Cells; 2004; 22(7):1239-45. PubMed ID: 15579642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
    Cittadini A; Monti MG; Petrillo V; Esposito G; Imparato G; Luciani A; Urciuolo F; Bobbio E; Natale CF; Saccà L; Netti PA
    Eur J Heart Fail; 2011 Dec; 13(12):1264-74. PubMed ID: 22045926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor delivery through self-assembling peptide scaffolds.
    Miller RE; Kopesky PW; Grodzinsky AJ
    Clin Orthop Relat Res; 2011 Oct; 469(10):2716-24. PubMed ID: 21503788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of mesenchymal stem cells with self-assembling polypeptide scaffolds is conducive to treating myocardial infarction in rats.
    Cui XJ; Xie H; Wang HJ; Guo HD; Zhang JK; Wang C; Tan YZ
    Tohoku J Exp Med; 2010 Dec; 222(4):281-9. PubMed ID: 21139379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers.
    Hsieh PC; Davis ME; Gannon J; MacGillivray C; Lee RT
    J Clin Invest; 2006 Jan; 116(1):237-48. PubMed ID: 16357943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction.
    Enoki C; Otani H; Sato D; Okada T; Hattori R; Imamura H
    Int J Cardiol; 2010 Jan; 138(1):9-18. PubMed ID: 19411121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair.
    Lin YD; Luo CY; Hu YN; Yeh ML; Hsueh YC; Chang MY; Tsai DC; Wang JN; Tang MJ; Wei EI; Springer ML; Hsieh PC
    Sci Transl Med; 2012 Aug; 4(146):146ra109. PubMed ID: 22875829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenic peptide nanofibers repair cardiac tissue defect after myocardial infarction.
    Rufaihah AJ; Yasa IC; Ramanujam VS; Arularasu SC; Kofidis T; Guler MO; Tekinay AB
    Acta Biomater; 2017 Aug; 58():102-112. PubMed ID: 28600129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined administration of mesenchymal stem cells overexpressing IGF-1 and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.
    Gómez-Mauricio G; Moscoso I; Martín-Cancho MF; Crisóstomo V; Prat-Vidal C; Báez-Díaz C; Sánchez-Margallo FM; Bernad A
    Stem Cell Res Ther; 2016 Jul; 7(1):94. PubMed ID: 27423905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategic advantages of insulin-like growth factor-I expression for cardioprotection.
    Chao W; Matsui T; Novikov MS; Tao J; Li L; Liu H; Ahn Y; Rosenzweig A
    J Gene Med; 2003 Apr; 5(4):277-86. PubMed ID: 12692862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.